NOL4 and melanoma: In addition, NOL4 mRNA was expressed weakly, detected at a low frequency, or not detected, in non-small-cell lung cancer, ovarian cancer, breast cancer, mesothelioma, colon cancer, melanoma, and hepatocellular carcinoma (Figure 2).